Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

OTHER 6 OTHER_GOV 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1

Interventions

Cisplatin 49 Capecitabine 41 apatinib 34 Gemcitabine 33 Oxaliplatin 32 Cyclophosphamide 31 Radiotherapy 29 Paclitaxel 29 Carboplatin 29 tislelizumab 27 Irinotecan 27 Drug Therapy 27 Fluorouracil 26 Docetaxel 26 Bevacizumab 23 fludarabine 18 Surgical Procedures, Operative 17 Nivolumab 17 pembrolizumab 16 Exercise 16 Metformin 15 camrelizumab 14 S 1 (combination) 14 Radiation 14 Pemetrexed 13 Control Groups 12 anlotinib 11 Leucovorin 11 toripalimab 10 Vinorelbine 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Interventional × empagliflozin × Clear all

NCT03008551 2019-07-15

Empagliflozin vs Metformin in PCOS

Hull University Teaching Hospitals NHS Trust

Phase 2/3 Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡